Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566083 · ClinicalTrials.gov registry record · NA
Post-Approval Study of the Tecnis® Toric IOL
A NA study, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- NA
- Development phase
- 365
- Enrollment target
NCT02566083: Completed NA study, sponsored by Abbott Medical Optics.
NCT02566083 is a NA study that has completed, run by Abbott Medical Optics. The registered enrollment target is 365 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566083, a NA study, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- NA
- Development phase
- 365 participants
- Enrollment target
Study Summary
This study is a prospective, multicenter, bilateral, non-randomized, open-label, comparative clinical study conducted at up to 80 sites in the USA. Subjects will choose to be bilaterally implanted with either 1) the TECNIS 1-Piece Toric IOLs, Model ZCT300 and/or ZCT400, or 2) the TECNIS Monofocal Model ZCB00 non-toric control IOL, according to subject preference
Primary Outcome
The rate of severe visual distortions under overall circumstances for the five visual distortion items of interest (lines that slant, tilt, split or separate; flat surfaces appearing curved; objects appearing further away or closer than they are; objects appearing to have a different size or shape; and physical discomfort related to vision). The six month data were used for this endpoint if available and if not an earlier visit was used. If a subject had a lens repositioning the questionnaire pr
Interventions
- DEVICE non-toric intraocular lens
- DEVICE toric intraocular lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2015-10-21 |
| Est. Completion | 2019-05-23 |
| Phase | NA |
What the finished NCT02566083 record still lists
NCT02566083 is an interventional study that assigns participants to a tested intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which non-toric intraocular lens is the first listed.
NCT02566083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566083 about?
NCT02566083 is a clinical study titled "Post-Approval Study of the Tecnis® Toric IOL". This study is a prospective, multicenter, bilateral, non-randomized, open-label, comparative clinical study conducted at up to 80 sites in the USA. Subjects will choose to be bilaterally implanted with either 1) the TECNIS 1-Piece Toric IOLs, Model ZCT300 and/or ZCT400, or 2) the TECNIS Monofocal Mo...
What is the current status of trial NCT02566083?
This trial is currently completed. It is a NA study. The enrollment target is 365 participants. The study started on 2015-10-21. Estimated completion is 2019-05-23.
What interventions are being tested in trial NCT02566083?
The interventions under investigation include: non-toric intraocular lens (DEVICE), toric intraocular lens (DEVICE).
Who is sponsoring clinical trial NCT02566083?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02566083's enrollment target sits among peer trials
365 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI